Prospective study on the impact of different antithrombotic therapies on subclinical leaflet thickening and its temporal dynamics in transcatheter aortic valves—The NOTION-4 trial
- 5 October 2024
- journal article
- research article
- Published by Elsevier in American Heart Journal
- Vol. 279, 1-8
Abstract
No abstract availableKeywords
Funding Information
- Novo Nordisk Foundation
This publication has 18 references indexed in Scilit:
- A Comparative Study of Transcatheter Aortic Valve Implantation Views for Two Different Self-Expanding Aortic ValvesStructural Heart, 2024
- Apixaban and Valve Thrombosis After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2022
- Long-Term Follow-Up of Hypoattenuated Leaflet Thickening After Transcatheter Aortic Valve ReplacementJACC: Cardiovascular Interventions, 2022
- Valve Academic Research Consortium 3: Updated Endpoint Definitions for Aortic Valve Clinical ResearchJACC, 2021
- Subclinical Leaflet Thrombosis in Transcatheter and Surgical Bioprosthetic ValvesJACC, 2020
- Bioprosthetic Aortic Valve Leaflet Thickening in the Evolut Low Risk Sub-StudyJACC, 2020
- Computed Tomography Imaging in the Context of Transcatheter Aortic Valve Implantation (TAVI)/Transcatheter Aortic Valve Replacement (TAVR)JACC: Cardiovascular Imaging, 2019
- Variation in post-TAVR antiplatelet therapy utilization and associated outcomes: Insights from the STS/ACC TVT RegistryAmerican Heart Journal, 2018
- Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational studyThe Lancet, 2017
- Trial design: Rivaroxaban for the prevention of major cardiovascular events after transcatheter aortic valve replacement: Rationale and design of the GALILEO studyAmerican Heart Journal, 2017